GoodRx Holdings, Inc. (GDRX)
NASDAQ: GDRX · Real-Time Price · USD
3.430
+0.070 (2.08%)
Oct 9, 2026, 4:00 PM EDT - Market closed
GoodRx Holdings Stock Forecast
Stock Price Forecast
According to 14 analysts polled by S&P Global, GoodRx Holdings stock has a consensus rating of "Hold" and an average price target of $3.95. The average 1-year stock price forecast is 15.16% higher than the current stock price, while the lowest is $2.65 (-22.74%) and the highest is $5.00 (+45.77%).
Price Target: $3.95 (+15.16%)
Analyst Consensus: Hold
Price Target
ChartAnalyst Ratings
The average analyst rating for GoodRx Holdings stock is "Hold". This means that analysts believe this stock is likely to perform similarly to the overall market.
Recommendation Trends
| Rating | May '26 | Jun '26 | Jul '26 | Aug '26 | Sep '26 | Oct '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 4 | 4 | 4 | 4 | 3 | 3 |
| Buy | 1 | 1 | 1 | 1 | 1 | 1 |
| Hold | 8 | 8 | 8 | 8 | 8 | 8 |
| Sell | 2 | 2 | 2 | 2 | 2 | 2 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 15 | 15 | 15 | 15 | 14 | 14 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Bank of America Securities | Bank of America Securities | Sell Maintains $2.65 | Sell | Maintains | $2.65 | -22.74% | Sep 15, 2026 |
| Barclays | Barclays | Sell Maintains $3 → $4 | Sell | Maintains | $3 → $4 | +16.62% | Aug 20, 2026 |
| Truist Financial | Truist Financial | Hold Reiterates n/a | Hold | Reiterates | n/a | n/a | Aug 14, 2026 |
| UBS | UBS | Hold Maintains $2.5 → $3.75 | Hold | Maintains | $2.5 → $3.75 | +9.33% | Aug 13, 2026 |
| TD Cowen | TD Cowen | Buy Reiterates $4 → $5 | Buy | Reiterates | $4 → $5 | +45.77% | Aug 11, 2026 |
Financial Forecast
Revenue This Year
798.28M
from 796.85M
Increased by 0.18%
Revenue Next Year
838.66M
from 798.28M
Increased by 5.06%
EPS This Year
0.30
from 0.35
Decreased by -13.42%
EPS Next Year
0.35
from 0.30
Increased by 17.07%
EPS and Forward PE are based on non-GAAP adjusted numbers.